Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Toi

Showing results (41-50 of 222) with videos related to

Pageof 23
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors]M Toi, G Matsumoto, H Bando, et al.
Oncology Reports|May 25, 2011
Preventive effect of whole peptidoglycan (wpg) on the occurrence of rat mammary-tumors induced by 7,12-dimethylbenz(a)anthracene (dmba)M Kitamura, K Takahashi, T Tominaga, et al.
Oncology Reports|May 20, 2011
Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumorsM Kitamura, K Arai, Y Iwasaki, et al.
Breast Cancer Research and Treatment|January 1, 1995
Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expressionM Toi, K Inada, H Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1995
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]M Toi, T Taniguchi, K Hayashi, et al.
Oncology Reports|May 21, 2011
Combination effect of an angiogenesis inhibitor agm-1470 with 5'-deoxy-5-fluorouridine, and with hormonal drugs in dmba-induced rat mammary-tumorsY Yamamoto, M Toi, R Yamada, et al.
Journal of Clinical Pathology|October 2, 2002
Alpha smooth muscle actin positive stromal cells in gastric carcinomaH Nakayama, H Enzan, E Miyazaki, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Epidermal growth factor receptor expression as a prognostic indicator in breast cancerM Toi, A Osaki, H Yamada, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 30, 2006
Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patientsT Ueno, L W C Chow, M Toi
Histology and Histopathology|January 1, 2003
Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspectsN Kuroda, M Toi, M Hiroi, et al.
Pageof 23

Showing results (41-50 of 222) with videos related to

Sort By:
Pageof 23
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors]M Toi, G Matsumoto, H Bando, et al.
Oncology Reports|May 25, 2011
Preventive effect of whole peptidoglycan (wpg) on the occurrence of rat mammary-tumors induced by 7,12-dimethylbenz(a)anthracene (dmba)M Kitamura, K Takahashi, T Tominaga, et al.
Oncology Reports|May 20, 2011
Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumorsM Kitamura, K Arai, Y Iwasaki, et al.
Breast Cancer Research and Treatment|January 1, 1995
Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expressionM Toi, K Inada, H Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1995
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]M Toi, T Taniguchi, K Hayashi, et al.
Oncology Reports|May 21, 2011
Combination effect of an angiogenesis inhibitor agm-1470 with 5'-deoxy-5-fluorouridine, and with hormonal drugs in dmba-induced rat mammary-tumorsY Yamamoto, M Toi, R Yamada, et al.
Journal of Clinical Pathology|October 2, 2002
Alpha smooth muscle actin positive stromal cells in gastric carcinomaH Nakayama, H Enzan, E Miyazaki, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Epidermal growth factor receptor expression as a prognostic indicator in breast cancerM Toi, A Osaki, H Yamada, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 30, 2006
Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patientsT Ueno, L W C Chow, M Toi
Histology and Histopathology|January 1, 2003
Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspectsN Kuroda, M Toi, M Hiroi, et al.
Pageof 23